Abstract
Nasopharyngeal carcinoma (NPC), an endemic head and neck cancer found in Southeast Asia, is etiologically associated with the infection of an oncogenic virus, the Epstein-Barr virus (EBV). Here, we review literature findings on the potential/putative role of STAT3 signaling in its pathogenesis and discuss anti-STAT3 targeting as a therapeutic and possibly prevention strategy for NPC. Lastly, the potential involvement of STAT3 in other oncovirus-associated (e.g. the human papillomavirus) head and neck cancers have not been investigated and we hope that findings in EBV-associated NPC can prompt future investigations in these cancers, which are of increasing impact in the Western countries.
Original language | English (US) |
---|---|
Pages (from-to) | 141-149 |
Number of pages | 9 |
Journal | Cancer Letters |
Volume | 330 |
Issue number | 2 |
DOIs | |
State | Published - Apr 28 2013 |
Externally published | Yes |
Keywords
- EBV
- Head and neck cancers
- Molecular targeting
- Nasopharyngeal cancer
- STAT3
ASJC Scopus subject areas
- Oncology
- Cancer Research